C07K 16/116
Togaviridae
Official title: Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
C07K16/116 (Togaviridae) appears on 406 US grants and 557 published applications in this corpus.
Search patents in C07K- Granted patents
- 406
- Published applications
- 557
- Assignees
- 305
- Inventors
- 1,071
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 12 | 0 |
| 1999 | 6 | 0 |
| 2000 | 9 | 0 |
| 2001 | 4 | 0 |
| 2002 | 3 | 11 |
| 2003 | 7 | 21 |
| 2004 | 8 | 21 |
| 2005 | 10 | 11 |
| 2006 | 9 | 20 |
| 2007 | 13 | 17 |
| 2008 | 11 | 15 |
| 2009 | 14 | 27 |
| 2010 | 11 | 21 |
| 2011 | 8 | 18 |
| 2012 | 10 | 21 |
| 2013 | 16 | 17 |
| 2014 | 24 | 20 |
| 2015 | 10 | 24 |
| 2016 | 21 | 15 |
| 2017 | 10 | 26 |
| 2018 | 12 | 27 |
| 2019 | 20 | 39 |
| 2020 | 18 | 35 |
| 2021 | 21 | 37 |
| 2022 | 25 | 34 |
| 2023 | 23 | 23 |
| 2024 | 23 | 25 |
| 2025 | 15 | 15 |
| 2026 | 8 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Anti-dengue virus antibodies having cross-reactivity to zika virus and methods of use23 Jun 2026US 12,662,526 B2Agency for Science, Technology and Research
- Zika/dengue vaccine and application thereof2 Jun 2026US 12,642,846 B2Institute of Microbiology, Chinese Academy of Sciences
- Human monoclonal antibodies to Venezuelan equine encephalitis virus and uses therefor2 Jun 2026US 12,642,847 B2Vanderbilt University
- HIV/HCV cross-reactive antibodies and uses thereof12 May 2026US 12,624,091 B2Vanderbilt University
- Antibodies which specifically bind to dengue virus serotype 4 (DENV4) non-structural protein 1 (NS1) and methods of use thereof to detect a DENV4 infection21 Apr 2026US 12,606,611 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof17 Sep 2026US 2026/0274995 A1ModeX Therapeutics, Inc.
- Human broadly neutralizing monoclonal antibodies associated with hepatitisc virus clearance10 Sep 2026US 2026/0265351 A1The Johns Hopkins University
- Dengue vaccine3 Sep 2026US 2026/0256903 A1VLP Therapeutics, LLC
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
- Anti-dengue virus antibodies, polypeptides containing variant fc regions, and methods of use13 Aug 2026US 2026/0234225 A1Agency for Science, Technology and Research
Most cited
By later US patents
- HCV immunoassays employing C domain antigens147US 5,350,671 AChiron Corporation · 1994
- Gas inlet for a plurality of reactant gases into reaction vessel142US 5,441,703 AAixtron SE · 1995
- High potency immunogenic zika virus compositions92US 10,273,269 B2ModernaTX, Inc. · 2019
- Retro-, inverso- and retro-inverso synthetic peptide analogues90US 6,261,569 B1Deakin Research Limited · 2001
- Zika RNA vaccines85US 10,449,244 B2ModernaTX, Inc. · 2019